Abstract
Oral Immunotherapy (OIT) is a promising emerging therapy which facilitates desensitization; however, the amount of allergen that can be tolerated during accidental ingestions following OIT is unknown. The objective of this study is to summarize findings from four OIT trials to better understand predictors and the likelihood that participants were able to achieve ten times their initial dose.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
